Trade Cogent Biosciences, Inc. - COGT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 7.55 |
Open | 7.49 |
1-Year Change | 18.51% |
Day's Range | 7.44 - 7.74 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 12, 2025 | 7.55 | 0.26 | 3.57% | 7.29 | 7.71 | 7.24 |
Mar 11, 2025 | 7.20 | 0.51 | 7.62% | 6.69 | 7.24 | 6.57 |
Mar 10, 2025 | 6.81 | -0.01 | -0.15% | 6.82 | 6.99 | 6.57 |
Mar 7, 2025 | 6.96 | -0.44 | -5.95% | 7.40 | 7.42 | 6.85 |
Mar 6, 2025 | 7.37 | -0.14 | -1.86% | 7.51 | 7.62 | 7.24 |
Mar 5, 2025 | 7.63 | 0.49 | 6.86% | 7.14 | 7.71 | 7.14 |
Mar 4, 2025 | 7.14 | 0.35 | 5.15% | 6.79 | 7.23 | 6.75 |
Mar 3, 2025 | 6.95 | -0.48 | -6.46% | 7.43 | 7.54 | 6.95 |
Feb 28, 2025 | 7.49 | 0.58 | 8.39% | 6.91 | 7.50 | 6.86 |
Feb 27, 2025 | 6.95 | 0.36 | 5.46% | 6.59 | 7.29 | 6.59 |
Feb 26, 2025 | 6.66 | -0.43 | -6.06% | 7.09 | 7.10 | 6.52 |
Feb 25, 2025 | 6.95 | -0.42 | -5.70% | 7.37 | 7.37 | 6.81 |
Feb 24, 2025 | 7.42 | -0.41 | -5.24% | 7.83 | 7.83 | 7.41 |
Feb 21, 2025 | 7.95 | -0.07 | -0.87% | 8.02 | 8.16 | 7.86 |
Feb 20, 2025 | 8.04 | 0.02 | 0.25% | 8.02 | 8.05 | 7.83 |
Feb 19, 2025 | 8.03 | 0.10 | 1.26% | 7.93 | 8.12 | 7.93 |
Feb 18, 2025 | 8.05 | 0.10 | 1.26% | 7.95 | 8.24 | 7.91 |
Feb 14, 2025 | 7.98 | -0.15 | -1.85% | 8.13 | 8.32 | 7.94 |
Feb 13, 2025 | 8.14 | 0.03 | 0.37% | 8.11 | 8.21 | 7.92 |
Feb 12, 2025 | 8.10 | 0.00 | 0.00% | 8.10 | 8.28 | 7.92 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Cogent Biosciences, Inc. Company profile
About Cogent Biosciences Inc
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases. The Company's most advanced program is CGT9486, a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation, as well as other mutations in KIT exon 17, to treat Systemic Mastocytosis (SM) and gastrointestinal stromal tumors (GIST). GT9486 has demonstrated clinical activity and safety results in a Phase I/II clinical trial in patients with GIST, supporting accelerated timelines to proof-of-concept in SM.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cogent Biosciences Inc revenues decreased from $7.9M to $0K. Net loss applicable to common stockholders decreased 60% to $72.3M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Acquired in-process research and develop decrease from $46.9M (expense) to $0K, Other income increase from $779K to $2.5M (income).
Industry: | Bio Therapeutic Drugs |
275 Wyman Street
3rd Floor
WALTHAM
MASSACHUSETTS 02451
US
News

Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com